Published in Medical Patent Week, December 10th, 2006
Revenues for the third quarter of 2006 increased 23% to a record $18.6 million from $15.0 million for the third quarter of 2005. Gross profit margin increased 680 basis points to 60% of total revenues compared with 53% for the same period in 2005.
For the three months ended September 30, 2006, Cynosure recorded a net loss under Generally Accepted Accounting Principles (GAAP) of $4.2 million, or $0.38 per share, which includes a $10.0 million one-time...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Week